MedPath

Evaluation of the efficacy and suppression of the hypothalamic-pituitary-adrenal axis resulting in intrabursale single administration of cortisone in patients with calcific tendonitis of the rotator cuff '': randomized, controlled clinical trial

Conditions
calcific tendonitis of the rotator cuff
MedDRA version: 14.1Level: SOCClassification code 10028395Term: Musculoskeletal and connective tissue disordersSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders
Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
Registration Number
EUCTR2012-000866-40-IT
Lead Sponsor
ISTITUTO ORTOPEDICO RIZZOLI
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Patients of both sexes, aged between 30-50 years, suffering from painful calcific tendonitis of the shoulder (calcification or mature phase of resorption) confirmed by ultrasound examination.
Are the trial subjects under 18? no
Number of subjects for this age range: 0
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 40
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

• enthesitis calcific shoulder
• calcific tendinopathy with lesions of the rotator cuff
• Septic arthritis or infection of the superficial tissues or periarticular
• Disease hematologic or coagulation (liver failure ....)
• metabolic diseases (diabetes)
• Glaucoma
• Organ Transplant
• collagenopatiche diseases or systemic inflammatory rheumatic (SLE, RA ..)
• previous use of cortisone 2 months prior to TPE
• Concomitant therapy with anticoagulants and / or antiplatelet
• A history of asthma, allergic rhinitis, allergic conjunctivitis, bronchiectasis, sarcoidosis (erythema nodosum, uveitis ..), cystic fibrosis, COPD, Crohn's, ulcerative colitis
• are allergic to cortisone derivatives
• Pregnant or lactating
• Minors

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath